1.
AIDS
; 34(11): 1696-1697, 2020 09 01.
Article
in English
| MEDLINE
| ID: mdl-32769770
Subject(s)
Coronavirus Infections/epidemiology , HIV Infections/epidemiology , Pneumonia, Viral/epidemiology , Adult , Aged , Anti-Retroviral Agents/therapeutic use , Antiviral Agents/therapeutic use , Betacoronavirus , CD4 Lymphocyte Count , COVID-19 , Coinfection , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Coronavirus Infections/physiopathology , Female , HIV Infections/drug therapy , HIV Infections/immunology , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/epidemiology , Humans , Hydroxychloroquine/therapeutic use , Interferon beta-1b/therapeutic use , Lopinavir/therapeutic use , Male , Middle Aged , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/physiopathology , Protective Factors , Retrospective Studies , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Spain/epidemiology , Sustained Virologic Response , Viral Load , COVID-19 Drug Treatment
2.
Rev. esp. geriatr. gerontol. (Ed. impr.)
; 45(3): 172-173, abr.-jun. 2010.
Article
in Spanish
| IBECS
| ID: ibc-79811
3.
Rev Esp Geriatr Gerontol
; 45(3): 172-3, 2010.
Article
in Spanish
| MEDLINE
| ID: mdl-20398962